Navigation Links
Novalar Receives FDA Approval for OraVerse(TM)
Date:5/12/2008

First approved dental anesthetic reversal agent

SAN DIEGO, May 12 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced today that the United States Food and Drug Administration (FDA) has granted marketing approval for OraVerse(TM) (phentolamine mesylate). OraVerse is the first pharmaceutical agent indicated for the reversal of soft-tissue anesthesia and the associated functional deficits resulting from a local dental anesthetic. Novalar is establishing a specialty direct sales force to launch OraVerse in late 2008.

"The approval of OraVerse is the result of the outstanding efforts of our development team, our strong collaboration with the FDA and our focus and commitment to realizing the vision of our founder, Dr. Eckard Weber. This first-in-class therapeutic will provide dental professionals with a novel solution to enhance the overall experience for their patients," stated Donna Janson, President and Chief Executive Officer of Novalar.

Novalar plans to launch OraVerse at this year's American Dental Association (ADA) Annual Session being held in San Antonio, Texas from October 16-20, 2008. Novalar's sales force will focus on general and pediatric dentists for use in patients over six years of age.

Over 300 million cartridges of local dental anesthetic are sold each year in the U.S. alone. Although widely used, it frequently results in unnecessary and lingering soft tissue anesthesia and associated functional deficits. Novalar's market research with both patients and dentists has indicated strong interest in a product that will reduce the time to normal sensation and function following local dental anesthesia.

OraVerse's approval for use in adults and children is based on data from several clinical studies, including two Phase 3 studies in adults and adolescents age 12 and older and a Phase 2 pediatric study. The two Phase 3 studies were conducted in 18 centers across
'/>"/>

SOURCE Novalar Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
2. U.S. Navy Receives Funding for Further Development of Hemopure(R)
3. UCSF receives funding for building from California stem cell agency
4. USC receives nearly $27 million in funding for new stem cell research facility
5. Amneal Pharmaceuticals Receives US FDA Approval for Three Generic Prescription Drugs; Two Using New FDA Electronic Filing Format
6. Presbyterian Hospital of Plano Receives Prestigious Texas Award for Performance Excellence
7. Boston Medical Center/Boston University School of Medicine researcher receives award
8. Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
9. Quatro Composites Receives ISO 9001:2000 and AS9100:2004 Certification
10. Vascular Insights Receives FDA Clearance for Infusion Catheter
11. Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Fremont, California (PRWEB) March 03, 2015 ... remote access connectivity solutions, today announced the global ... (CESA 2.0). It delivers the world’s most deployed ... Microsoft Windows® Server 2012 R2. This new release ... R2 remote access platform from a single HTML ...
(Date:3/3/2015)... Auckland, New Zealand and Rockville, Maryland (PRWEB) March ... has selected Cornerstone Communications, LTD as its North ... record. Cornerstone was awarded the Manuka Lab contract ... beauty, and consumer verticals. , Headquartered in Auckland, ... private company focused on providing clients effective, certified ...
(Date:3/3/2015)... March 03, 2015 Venato, a ... announced that their flagship software solution now provides ... to be uploaded to the National Healthcare Safety ... Medicaid Services (CMS) require that hospitals submit healthcare ... no later than May 15 for each influenza ...
(Date:3/3/2015)... Raritan Bay Medical Center is proud to ... photo contest held at the Woodbridge Center Mall in ... awareness for health and wellness in the Central New ... health and wellness tips. , Photos of visitors sharing ... and Facebook page where Facebook users voted on their ...
(Date:3/3/2015)... 2015 Nutritional supplement e-tailer PureFormulas ... presenter at the third ecommerce Conference and Expo, ... Exhibition Centre March 10-12. , PureFormulas CMO Daniel ... 11 am (Melbourne time). His session, entitled “Tapping ... making each customer’s experience unique via personalization, as ...
Breaking Medicine News(10 mins):Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3Health News:Manuka Lab North America, Inc. Awards Cornerstone Communications, LTD North American Agency Contract 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2
... YORK, March 21 Haymarket Media Inc. is ... clinicians, The American,Journal of Hematology/Oncology and Oncology Nursing ... previously published by U.S.,HealthCare Communications, of Highland Park, ... a strong oncology presence to the Haymarket,clinical family," ...
... 21 In two weeks, on April,4, 2008, Deerfield Spa ... spa discounts. During the ten-day periods of April 4 to ... days for the price of one,week and receive a $70 ... in between -- from April 13 to 18, 2008 --,Deerfield ...
... increase in personal problems among adolescents with persistent sleeplessness, ... Science Center at Houston say they have completed the ... insomnia on 11 to 17 year olds. More than ... more symptoms of insomnia and almost half of these ...
... March 21 MEDai, Inc., headquartered in,Orlando, FL, ... that,utilize award-winning predictive analytics, has been helping health ... of predictive modeling.,At the upcoming World Research Group ... present a general session and,workshop that helps organizations ...
... recent survey by the Harvard School of Public Health (HSPH) ... Health: Election 2008, finds that Americans are generally split on ... health care system in the world (45% believe the U.S. ... systems; 15% dont know or refused to answer) and that ...
... bacteria in the blood , In developed ... usually occurs through eating contaminated food and causes gastroenteritis. ... 2 and HIV-infected adults usually develop an infection in ... quarter of affected children. There is currently no vaccine ...
Cached Medicine News:Health News:Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications 2Health News:Deerfield Spa, Voted Among 'Best Affordable Spas,' Opens 2008 Season With Discounts, Savings, Gifts, Specials 2Health News:Adolescents with chronic insomnia report 'twofold to fivefold' increase in personal problems 2Health News:MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 3Health News:JCI table of contents: March 20, 2008 2Health News:JCI table of contents: March 20, 2008 3Health News:JCI table of contents: March 20, 2008 4Health News:JCI table of contents: March 20, 2008 5
(Date:3/3/2015)... , March 3, 2015 Mapi ... Regulatory challenges through the drug development and commercialization process. ... include Global Strategic Regulatory services with the addition of ... previously announced acquisition . CanReg is one of ... exclusively to regulatory affairs for life sciences companies. With ...
(Date:3/3/2015)... SAN DIEGO , March 3, 2015 /PRNewswire/ ... has exclusively licensed Pomaglumetad Methionil (mGlu2/3 receptor agonist), ... Company (NYSE:   LLY). Denovo gains all rights ... transfer of all intellectual property and other rights, ... re-acquire pomaglumetad upon a successful clinical trial, for ...
(Date:3/3/2015)... British Columbia and MENLO PARK, Calif. ... (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company ... orphan drug indications, today announced that it will be presenting ... March 8-11, 2015, at The Ritz-Carlton, Laguna Niguel ... Jeffrey Bacha , DelMar,s president and ...
Breaking Medicine Technology:Mapi incorporates Strategic Regulatory Services to support life-science product Commercialization and Health Research 2Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine 2DelMar Pharmaceuticals to Present at the 27th Annual ROTH Conference on March 10, 2015 2DelMar Pharmaceuticals to Present at the 27th Annual ROTH Conference on March 10, 2015 3
... 14 Reportlinker.com announces that a new ... catalogue: Interventional Cardiology Devices ... Market Forecasts to 2016 ... Cardiology Devices - Global Pipeline Analysis, Opportunity ...
... 14 Reportlinker.com announces that a new ... catalogue: Global Renal Dialysis ... Forecasts to 2016 ... Dialysis Equipment Pipeline Analysis, Opportunity Assessment and ...
Cached Medicine Technology:Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 10Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 11Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 12Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 13Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 10Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 11Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 12
... The PowerPac HV high-voltage ... V, supports an increased output ... and 400 W. Built-in infrared ... transfer. Power cord and instructions ...
... free flowing powder EEO(-m r ): less than ... than or equal to 31C Remelt Point (3%): ... greater than or equal to 500 gm/cm 2 ... gm/cm 2 Moisture: less than or equal to ...
... SPECIFICATIONS Form: Granular, free-flowing powder EEO(-m r ): ... less than or equal to 35.5C Remelt Point ... Strength (1.5%): greater than or equal to 600 ... than or equal to 1500 gm/cm 2 Moisture: ...
... 5000 mg/kg sulfate (SO 4 ) ≤ 5000 mg/kg ... mg/kg Co ≤ 5 mg/kg Cr ≤ 5 mg/kg ... ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ≤ ... mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 mg/kg ...
Medicine Products: